Early Experience of TACE Combined with Atezolizumab Plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study.
Journal of oncology（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要